Seroprevalence and risk factors for hepatitis-B virus infection among general population in northern India

Arquivos de Gastroenterologia

Volumn 45, Issue 2, 2008, Pages 137-140

  Behal, Rachna ^a   Jain, Renu ^b   Behal, Krishan K ^a   Bhagoliwal, Ajay ^c   Aggarwal, Nakshatra ^d   Dhole, T N ^e  

^a CSJM UNIVERSITY   (India)

^b GSVM MEDICAL COLLEGE   (India)

^c S N MEDICAL COLLEGE   (India)

^d RS Diagnostic and Research Centre   (India)

^e SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Blood donors; Hepatitis B surface antigen; Hepatitis B virus; India; Risk factors; Seroepidemiologic studies

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RHESUS ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; STATISTICAL ANALYSIS;

EID: 48249093467     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032008000200009     Document Type: Article

References (35)

1. Aggarwal R. Universal neonatal Hepatitis B virus vaccination in India: why? Hep B Annual. 2004;1:60-71.
2. Asakura T, Tachibana K, Watanabe S, Teshima D, Ikeda M, Tokudome S. Concomitant carriage of hepatitis B virus and human T-lymphotropic virus type I among blood donors in Kitakyushu, Japan. J Infect. 1991;23:33-7.
3. Baikie M, Ratnam S, Bryant DG, Jong M, Bokhout M. Epidemiologic features of Hepatitis B virus infection in northern Labrador. CMAJ. 1989;141:791-5.
4. Chakraborthy MS, Mukherjee KK, Mithra KK. Association between Australia antigen between Australia and leprosy in Calcutta. Bull Cal School Trop Med. 1977;25:19-21.
5. Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness ofmandatory transmissible of mandatory diseases screening in Indian Blood donors. Ind J Med Res. 1995;105:229-32.
6. Chowdhury A. Epidemiology of Hepatitis B virus infection in India. 2004;1:17-24.
7. Dienstag JL, Isselbacher KJ. Acute viral Hepatitis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrisons Principles of Internal Medicine. New York: Mc Graw Hill; 1998. p.1677-92.
8. Dray X, Dray-Spira R, Bronstein JA, Mattera D. Prevalence of HIV, hepatitis B and hepatitis C in blood donors in the republic of Djibouti. Med Trop. 2005;65:39-42.
9. Elavia AJ, Banker DD. Hepatitis B Virus infection in hospital personnel. Natl Med J India. 1992;5:265-8.
10. Emeribe AO, Ejezie GC. ABO blood groups distribution in relation to Hepatitis B surface antigen and the presence of lipoidophil antibodies. East Afr Med J. 1992;69:146-8.
11. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and it's antibody in blood donors and high risk groups in Iran. Vox Sang. 1979;37:182-6.
12. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000;6(5-6):1114-6.
13. Hussain AI, Rajendran P, Thyagarajan SP. HBsAg and HIV antibody in tribal populations and HIV antibody of Tamilnadu, India. Virus Inf Exch New Lett 1991; 8: 62.
14. James L, Fong CW, Foong BH, Wee MK, Chow A, Shum E, Chew SK. Hepatitis B seroprevalence study 1999. Singapore Med J 2001;42:420-4.
15. Jayaprakash PA, Shanmugham J, Hariprasad D. Hepatitis B surface antigen in blood donors. An epidemiologic study. Transfusion. 1983;23:346-7.
16. Jayaram S. Prevalence of HBV markers in different age groups in Madras. (thesis) "Prevention and control of Hepatitis B in Tamil Nadu". University of Madras; 1992.
17. Khan M, Hussain M, Yano M, Hashizume K, Yousuf M, Tanaka E, Matsumoto A, Furuta S, Kiyosawa K. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan. Gastroenterol Jpn. 1993;28(Suppl 5):28-31.
18. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ 3rd. Changing epidemiology of hepatitis B in a US Community. Hepatol. 2004;39:811-6.
19. Kurien T, Thyagarajan SP, Jeyaseelan L, Peedicayil A, Rajendran P, Sivaram S, Hansdak SG, Renu G, Krishnamurthy P, Sudhakar K, Varghese JC, STD Study Group. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res. 2005;121:670-5.
20. Lo BB, Meymouna M, Boulahi MA, Tew M, Sow A, Ba A, Sow MB. Prevalence of serum markers of Hepatitis B and C virus in blood donors of Nouakchott, Mauritania. Bull Soc Pathol Exot. 1999;92:83-4.
21. Luksamijarulkul P, Thammata N, Tiloklurs M. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. Southeast Asian J Trop Med Public Health. 2002;33:272-9.
22. Mahoney FJ. Update on diagnosis, management and prevention of Hepatitis B virus infection. Clin Microbiol Rev. 1999;12:351-66.
23. Martelli CM, de Andrade AL, das Dores D, Cardoso P, Almeida e Silva S, Zicker F. Methodological considerations in the interpretation of serologic screening for hepatitis B virus among blood donors. Rev Saude Publica. 1991;25:11-6.
24. Mujeeb SA, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc. 2000;50:269-70.
25. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in North Indian voluntary and replacement blood donors: prevalence and trends: 1989-1996. Vox Sang. 1997;73:70-3.
26. Pal SR, Dutta DV, Choudhary S. HBsAg among patients with liver diseases and voluntary blood donors - a prospective study. Ind J Med Res. 1973;61:1784.
27. Rahlenbeck GI, Yohannes G, Molla K, Reifen R, Assefa A. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors. Int J STD AIDS. 1997;8:261-4.
28. Sakarya S, Oncu S, Ozturk B, Oncu S. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey. Saudi Med J. 2004;25:1070-2.
29. Sumathy S, Thyagarajan SP, Latif R, Madanagopalan N, Raguram K, Rajasambandam P, Gowans E. A dipstick immunobinding enzyme linked immunosorbent assay for serodiagnosis of hepatitis B and Delta virus infections. J Virol Methods. 1992;38:145-9.
30. Tandon BN, Joshi YK, Gandhi BM, Irshad M, Gupta H, Gupta ML. Epidemiology of HBsAg carriers in India. A holistic approach to control of hepatitis B reservoir. J Gastroenterol Hepatol. 1986;1:39-43
31. Thursz MR. Host genetic factors influencing the outcome of Hepatitis. J Viral Hepatitis. 1997;4:215-20.
32. Tsai SJ, Chen CJ, Hsieh YS, Yang CS. Seroprevalence of anti-HCV among voluntary blood donors in Taiwan. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1991;24:61-70.
33. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. High prevalence of Hepatitis B, C and delta virus infections among donors in Mongolia. Arch Virol. 2005;150:2513-28.
34. WHO - World Health Organization. Hepatitis B fact sheet number 204/WHO. (revised October 2000). Available: (http://who.int/inf.fs/en/fact204.html.)
35. Zekeng L, Kaptue L. HIV-1 serology and carrier state for HBs and HBe in blood donors at Yaounde University Hospital Centre, Cameroon. Ann Soc Belg Med Trop. 1990;70:49-53.